![]() |
市場調查報告書
商品編碼
1784620
2021-2031年北美雷射輔助耳鼻喉手術市場報告(範圍、細分、動態和競爭分析)North America Laser-Assisted ENT Surgery Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis |
北美雷射輔助耳鼻喉手術市場規模預計將從 2023 年的 1,20,527.14 千美元增至 2031 年的 2,45,109.60 千美元。預計 2023 年至 2031 年期間該市場的複合年成長率為 9.3%。
執行摘要和北美雷射輔助耳鼻喉手術市場分析:
慢性鼻竇炎等耳鼻喉疾病的盛行率不斷上升,推動了加拿大對有效治療方案的需求。例如,據加拿大家庭醫生稱,鼻竇炎是一種常見疾病,大約每8個加拿大成年人中就有1人患有此病。人口老化和人們對耳鼻喉健康問題的認知不斷提高,有利於加拿大雷射輔助耳鼻喉手術市場的發展。
北美雷射輔助耳鼻喉手術市場細分分析:
有助於得出雷射輔助耳鼻喉手術市場分析的關鍵部分是雷射類型、手術類型和最終用戶。
根據雷射類型,雷射輔助耳鼻喉手術市場細分為二氧化碳雷射、Nd:YAG雷射、二極體雷射、藍光雷射、KTP雷射、氬雷射和其他雷射類型。二氧化碳雷射在2023年佔據了最大的市場佔有率。
就手術類型而言,雷射輔助耳鼻喉手術市場分為雷射喉部手術、雷射內視鏡鼻竇手術(較少)、雷射輔助懸雍垂腭咽成形術 (LAUP)、雷射輔助鐙骨切開術、雷射輔助扁桃體切除術和腺樣體切除術、雷射鼻甲縮小術、經口雷射顯微手術 (TLM)、鼻腔手術和其他手術類型。 2023 年,雷射輔助扁桃體切除術和腺樣體切除術佔據了最大的市場佔有率。
根據最終用戶,雷射輔助耳鼻喉手術市場可分為醫院和專科診所、醫生辦公室和其他最終用戶。醫院和專科診所在2023年佔據了最大的市場。
北美雷射輔助耳鼻喉手術市場展望
慢性鼻竇炎、睡眠呼吸中止症、聽力損失以及各種頭頸部腫瘤等疾病日益普遍,需要先進的外科手術介入。雷射輔助手術因其微創特性,提供了一種極具吸引力的解決方案,這也迎合了越來越多的患者對快速恢復和術後不適感較少的手術的偏好。根據2024年發表在《鼻科學》雜誌上的一篇文章,慢性鼻竇炎的盛行率為5%-12%,其中20%的患者患有鼻息肉。
隨著全球人口老化,對耳鼻喉疾病有效創新治療方案的需求也隨之激增。此外,環境因素進一步加劇了耳鼻喉相關疾病的發生率。根據美國國家老齡委員會的數據,聽力損失影響約 6,070 萬 12 歲及以上的美國人。約 15.5%(4,410 萬)的 20 歲及以上的美國成年人患有聽力損失。此外,耳鼻喉疾病盛行率的不斷上升也伴隨著人們對早期診斷和治療重要性的認知的不斷提高。隨著患者對自己的健康選擇比以往任何時候都更加了解,他們更願意尋求先進的治療方法,從而從根本上重塑了耳鼻喉科治療的格局。診斷工具的技術進步促進了耳鼻喉疾病的早期發現,進一步推動了這一趨勢。因此,一旦患者被診斷出來,需要手術介入的可能性就會增加,從而推動了雷射輔助手術的數量。
北美雷射輔助耳鼻喉手術市場國家洞察
按國家分類,北美雷射輔助耳鼻喉手術市場包括美國、加拿大和墨西哥。美國在2023年佔最大佔有率。
西爾維斯特綜合癌症中心是美國第一家使用 445 nm 藍色雷射治療早期聲門癌(最常見的喉癌類型)的醫院。美國約有 2,000 名耳科醫生。他們中的許多人使用 532 nm 雷射系統進行鐙骨切除術和鐙骨切開術,以矯正某些類型的聽力損失。在美國,幾種經 FDA 批准的耳鼻喉雷射設備,特別是二氧化碳雷射設備,因其精確度和對周圍組織的熱損傷最小而廣泛用於腺樣體切除術和喉部手術等手術。此外,Nd:YAG 雷射系統是二極體雷射,通常用於治療鼻塞等疾病和進行雷射輔助懸雍垂腭咽成形術。美國食品藥物管理局也批准了 BIOLASE 的 EPIC 10 軟組織雷射用於耳鼻喉外科手術。隨著越來越多的醫療機構採用FDA核准的雷射器,患者的復原時間可望縮短,手術精準度也將提高,進而改善治療效果。 FDA對這些設備的批准至關重要,它能夠確保這些設備符合嚴格的安全性和有效性標準,並增強醫療服務提供者和患者的信心。
北美雷射輔助耳鼻喉手術市場公司概況
市場上的一些主要參與者包括 biolitec AG (Biolitec)、Iridex Corporation、Medency、Dimed Laser Technology Co., Ltd.、intros Medical Laser GmbH、ARC Laser GmbH、LightScalpel、GIGAAMEDICAL、INTERmedic ARFRAN、Limmer Laser GmbH、Qolight這些參與者正在採用擴張、產品創新和併購等各種策略,為消費者提供創新產品並增加市場佔有率。
北美雷射輔助耳鼻喉手術市場研究方法:
本報告中的資料收集和分析遵循了以下方法:
二手資料研究:研究流程始於全面的二手資料研究,利用內部和外部資源收集每個市場的定性和定量資料。常用的二手資料研究來源包括但不限於:
公司網站、年度報告、財務報表、經紀商分析和投資者介紹。行業期刊及其他相關出版品。政府文件、統計資料庫和市場報告。針對在市場營運的公司的新聞文章、新聞稿和網路廣播。註:公司簡介部分所包含的所有財務資料均已標準化為美元。對於以其他貨幣報告的公司,數據已使用相應年份的相關匯率轉換為美元。
一手研究 Insight Partners 每年都會與行業利益相關者和專家進行大量的一手調查,以驗證其資料分析,並獲得寶貴的見解。這些研究訪談旨在:
驗證並完善二手資料研究的結果。提升分析團隊的專業知識和市場理解。深入了解市場規模、趨勢、成長模式、競爭動態和未來前景。一手資料研究透過電子郵件互動和電話訪談進行,涵蓋不同地區的各種市場、類別、細分市場和次細分市場。參與者通常包括:
產業利害關係人:副總裁、業務發展經理、市場情報經理和國家銷售經理外部專家:估值專家、研究分析師和具有行業專業知識的關鍵意見領袖
The North America Laser-Assisted ENT Surgery Market size is expected to reach US$ 2,45,109.60 thousand by 2031 from US$ 1,20,527.14 thousand in 2023. The market is estimated to record a CAGR of 9.3% from 2023 to 2031.
Executive Summary and North America Laser-Assisted ENT Surgery Market Analysis:
The rising prevalence of ENT disorders, such as chronic sinusitis, is propelling the demand for effective treatment options in Canada. For instance, according to Canadian Family Physician, rhinosinusitis is common, afflicting approximately 1 in 8 adults in Canada. Population aging and increasing awareness regarding ENT health issues benefit the laser-assisted ENT surgery market in the country.
North America Laser-Assisted ENT Surgery Market Segmentation Analysis:
Key segments that contributed to the derivation of the laser-assisted ENT surgery market analysis are laser type, surgery type, and end user.
By laser type, the laser-assisted ENT surgery market is segmented into CO2 laser, Nd:YAG laser, diode laser, blue laser, KTP laser, argon laser, and other laser types. The CO2 laser held the largest share of the market in 2023.
In terms of surgery type, the laser-assisted ENT surgery market is divided into laser laryngeal surgery, laser endoscopic sinus surgery (less), laser-assisted uvulopalatoplasty (LAUP), laser-assisted stapedotomy, laser-assisted tonsillectomy and adenoidectomy, laser turbinate reduction, transoral laser microsurgery (TLM), nasal surgery, and other surgery types. The laser-assisted tonsillectomy and adenoidectomy segment held the largest share of the market in 2023.
Based on end user, the laser-assisted ENT surgery market is categorized into hospitals and specialty clinics, physician office, and other end-users. The hospitals and specialty clinics segment held the largest share of the market in 2023.
North America Laser-Assisted ENT Surgery Market Outlook
Conditions such as chronic sinusitis, sleep apnea, hearing loss, and various tumors of the head and neck are becoming more common, necessitating advanced surgical interventions. Laser-assisted surgeries offer a compelling solution due to their minimally invasive nature, which aligns with the growing preference among patients for procedures that promise quick recovery times and less postoperative discomfort. According to an article published in Rhinology in 2024, the prevalence range of chronic rhinosinusitis is 5-12%; from this, 20% have nasal polyps worldwide.
As the global population ages, the demand for effective and innovative treatment options for ENT (i.e., ear, nose, and throat) disorders surges in tandem. Also, environmental factors further worsen ENT-related conditions. According to the National Council on Aging, Inc., hearing loss affects about 60.7 million Americans aged 12 and older. About 15.5% (44.1 million) of American adults aged 20 and older have hearing loss. Further, the increasing prevalence of ENT disorders is accompanied by a heightened awareness of the importance of early diagnosis and treatment. As patients are more informed than ever about their health options, they willingly seek advanced therapies, thereby fundamentally reshaping the landscape of otolaryngological treatments. This trend is bolstered by technological advancements in diagnostic tools, which facilitate earlier detection of ENT conditions. Thus, as soon as patients are diagnosed, the likelihood of requiring surgical intervention increases, propelling the number of laser-assisted surgeries.
North America Laser-Assisted ENT Surgery Market Country Insights
Based on country, the North America laser-assisted ENT surgery market comprises the US, Canada, and Mexico. The US held the largest share in 2023.
The Sylvester Comprehensive Cancer Center was the first in the US to use the 445-nm blue laser for early glottic cancer treatment, the most common type of laryngeal cancer. There are approximately 2,000 otologists in the US. Many of them use 532-nm laser systems to perform stapedectomy and stapedotomy procedures to correct certain types of hearing loss. In the US, several FDA-approved ENT laser devices, notably CO2 laser devices, are widely used in procedures such as adenoidectomy and laryngeal surgery due to their precision and minimal thermal damage to surrounding tissues. Further, Nd: YAG laser systems are diode lasers that are commonly used to treat conditions such as nasal obstruction and perform laser-assisted uvulopalatoplasty. The US Food and Drug Administration has also cleared BIOLASE's EPIC 10 soft-tissue lasers for ENT surgical procedures. As more healthcare facilities adopt FDA-approved lasers, patient outcomes are likely to improve through reduced recovery times and enhanced procedural accuracy. The FDA's approval of these devices is crucial, ensuring they meet stringent safety and efficacy standards and fostering confidence among healthcare providers and patients.
North America Laser-Assisted ENT Surgery Market Company Profiles
Some of the key players operating in the market include biolitec AG (Biolitec); Iridex Corporation; Medency; Dimed Laser Technology Co., Ltd.; intros Medical Laser GmbH; ARC Laser GmbH; LightScalpel; GIGAAMEDICAL; INTERmedic ARFRAN; Limmer Laser GmbH; Qolight Medical Laser; and Sisram Medical Ltd., among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
North America Laser-Assisted ENT Surgery Market Research Methodology :
The following methodology has been followed for the collection and analysis of data presented in this report:
Secondary Research The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Company websites , annual reports, financial statements, broker analyses, and investor presentations. Industry trade journals and other relevant publications. Government documents , statistical databases, and market reports. News articles , press releases, and webcasts specific to companies operating in the market. Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.
Primary Research The Insight Partners' conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:
Validate and refine findings from secondary research. Enhance the expertise and market understanding of the analysis team. Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects. Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
Industry stakeholders : Vice Presidents, business development managers, market intelligence managers, and national sales managers External experts : Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise